Selective serotonin reuptake inhibitor discontinuation syndrome: A case report;Sindrome da sospensione da SSRI: Un contributo clinico

Italian Journal of Psychopathology

Volumn 10, Issue 2, 2004, Pages 291-295

  Bani, Alessandro ^a,b   Miniati, M ^a  

^a OSPEDALE DEGLI INFERMI   (Italy)

^b NONE   (Italy)

Author keywords

Discontinuation emergent events; Paroxetine; SSRI; Withdrawal Syndrome

Indexed keywords

PAROXETINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; CASE REPORT; DIZZINESS; DRUG WITHDRAWAL; FEMALE; HUMAN; LIBIDO DISORDER; MENTAL DISEASE; MENTAL INSTABILITY; PANIC; PSYCHOPHARMACOTHERAPY; REVIEW; SYMPTOMATOLOGY; WITHDRAWAL SYNDROME;

EID: 14644430327     PISSN: 15921107     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Barbui C, Campomori A, D'Avanzo B, Negri E, Garattini S. Antidepressant drug use in Italy since the introduction of SSRIs: national trends, regional differences and impact on suicide rates. Soc Psychiatry Psychiatr Epidemiol 1999;34:152-6.
2. Tyrer P. Clinical effects of abrupt withdrawal from TCA and IMAO after long term treatment. J Affect Disord 1984;6:1-7.
3. Medawar C. The antidepressant web. Marketing depression and making medicine work. Int J Risk Saf Med 1997;10:75-126.
4. Lader M. Benzodiazepine Withdrawal states. In: Trimble MR, ed. Benzodiazepines Divided. New York NY: John Wiley & Sons 1983:17-31.
5. Ellison JM. Dr. Ellison replies (letter). J Clin Psychiatry 1996;57:310.
6. Haddad P. Newer antidepressants and discontinuation syndrome. J Clin Psychiatry 1997;58(Suppl 7):17-22.
7. Bani A, Cassano GB. La sospensione del trattamento con sostanze psicoattive. In: Psichiatria Medica, Utet 1990.
8. Dilsaver SC, Feinberg M, Greden JF. Antidepressant withdrawal symptoms treated with anticholinergic agents. Am J Psychiatry 1983;140:249-51.
9. Ellison JM. SSRI Withdrawal buzz (letter). Am J Psychiatry 1993;55:544-5.
10. Farah A, Lauer T. Possible venlafaxine withdrawal reaction (letter). Am J Psychiatry 1996;153:576.
11. Mallya G, White K, Gunderson C. Is there a serotoninergic withdrawal syndrome? Biol Psychiatry 1993;33:851-2.
12. Stoukides JA, Stoukides CA. Extrapyramidal symptoms upon discontinuation of fluoxetine (letter). Am J Psychiatry 1991;148:1263.
13. Bhaumik S, Wildgust HJ. Letter to the Editor. Hum Psychopharmacol 1996;11:337-8.
14. Coupland NJ, Bell CJ, Potokar JP. Serotonin reuptake inhibitor withdrawal. J Clin Psychopharmacol 1996;16:356-62.
15. Rosenbaum J, Fava M, Hoog SL, Ascroft R, Krebs WB. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biol Psychiatry 1998;44:77-87.
16. Tarolla E, D'Andrea A, Cantelmi T. Paroxetina: tossicità, tollerabilità e usi atipici nella pratica clinica. Ital J Psychopathol 2003;9:163-71.
17. Mori S, Perez J, Tardito D. I citocromi p450. Dalla biologia alla terapia antidepressiva. Milano: Masson 1999.
18. D'Arcy PF. Dystonia and Withdrawal symptoms with paroxetine (letter). Int Pharm J 1993;7:140.
19. Pacheco L, Malo P, Aragues E. More cases of paroxetine withdrawal syndrome (letter). Br J Psychiatry 1996;169:384.
20. Pyke RE. Paroxetine Witdrawal syndrome (letter). Am J Psychiatry 1995;152:149-50.
21. Iapichino S, Colzi A, Massimo V. Inibitori selettivi del reuptake della serotonina - ISRS - Sindrome da sospensione: fattori patogenetici e differenziazione tra i diversi SSRI. Ital J Psychopathol 2000;6:180-6.
22. Barr LC, Goodman WK, Price LH. Physical symptoms associated with paroxetine discontinuation (letter). Am J Psychiatry 1994;151:289.
23. Dilsaver SC, Greden JF, Snider RM. Antidepressant withdrawal syndromes phenomenology and phisiopathology. Int Clin Psychopharmacol 1987;2:1-19.